These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2484199)

  • 21. 14th International HLA and Immunogenetics Workshop: report of progress in methodology, data collection, and analyses.
    Single RM; Meyer D; Mack SJ; Lancaster A; Erlich HA; Thomson G
    Tissue Antigens; 2007 Apr; 69 Suppl 1():185-7. PubMed ID: 17445197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computer algorithm that predicts both acceptable and unacceptable private and public HLA class I antigens in highly sensitized patients.
    Thompson JS; Bryne JE; Hempel HO; Oldfather JW; Green WF; Crowe DO; Sanfilippo F; MacQueen JM; McCalmon RN; Tardiff GN
    Transplant Proc; 1993 Feb; 25(1 Pt 1):251-4. PubMed ID: 8438290
    [No Abstract]   [Full Text] [Related]  

  • 23. Solid phase testing in the HLA laboratory: implications for organ allocation.
    Eckels DD
    Int J Immunogenet; 2008 Aug; 35(4-5):265-74. PubMed ID: 18479450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The epitope recognized by pan-HLA class I-reactive monoclonal antibody W6/32 and its relationship to unusual stability of the HLA-B27/beta2-microglobulin complex.
    Tran TM; Ivanyi P; Hilgert I; Brdicka T; Pla M; Breur B; Flieger M; Ivasková E; Horejsí V
    Immunogenetics; 2001 Aug; 53(6):440-6. PubMed ID: 11685454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expression of major histocompatibility antigens on human articular chondrocytes.
    Lance EM; Kimura LH; Manibog CN
    Clin Orthop Relat Res; 1993 Jun; (291):266-82. PubMed ID: 7684959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The specificity of anti-HLA class II monoclonal antibodies in cattle.
    Nilsson PR; Marsh SG; Joosten I; Nieuwland MG; Hensen EJ; Grosfeld-Stulemeyer MC; Mikko S; Gelhaus A; Schreuder GM
    Eur J Immunogenet; 1997 Jun; 24(3):211-23. PubMed ID: 9226127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA 1992: typing strategies and perspectives in bone marrow transplantation.
    Charron DJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):171-2. PubMed ID: 8438262
    [No Abstract]   [Full Text] [Related]  

  • 28. Population samples and genotyping technology.
    Mack SJ; Sanchez-Mazas A; Single RM; Meyer D; Hill J; Dron HA; Jani AJ; Thomson G; Erlich HA
    Tissue Antigens; 2007 Apr; 69 Suppl 1():188-91. PubMed ID: 17445198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Achievements and limitations of histocompatibility testing for ten HL-A factors in kidney transplantation.
    Perkins HA; Kountz SL; Payne R; Belzer FO
    Transplant Proc; 1971 Mar; 3(1):130-2. PubMed ID: 4106293
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunogenetics.
    van Rood JJ
    Curr Opin Hematol; 1994 Nov; 1(6):429-34. PubMed ID: 9371318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA expression and cancer--14th IHIWS immunohistochemistry quality control exercise exchange results.
    Chew SF; Kanaan C; Tait BD
    Tissue Antigens; 2007 Apr; 69 Suppl 1():248-51. PubMed ID: 17445213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T cell clones and monoclonal antibodies: immunologic probes of major histocompatibility complex class I molecules.
    Bluestone JA; Potter T
    Chem Immunol; 1989; 46():23-48. PubMed ID: 2514705
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunogenetics and polymyalgia rheumatica.
    Hunder G
    Br J Rheumatol; 1990 Oct; 29(5):321-2. PubMed ID: 1699624
    [No Abstract]   [Full Text] [Related]  

  • 34. 14th International HLA and Immunogenetics Workshop: report on the immunogenetics of aging.
    Naumova E; Pawelec G; Ivanova M; Constantinescu I; Bogunia-Kubik K; Lange A; Qguz F; Carin M
    Tissue Antigens; 2007 Apr; 69 Suppl 1():304-10. PubMed ID: 17445222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation.
    Le Bas-Bernardet S; Hourmant M; Valentin N; Paitier C; Giral-Classe M; Curry S; Follea G; Soulillou JP; Bignon JD
    Transplantation; 2003 Feb; 75(4):477-82. PubMed ID: 12605113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The human major histocompatibility system.
    Thorsby E
    Transplant Rev; 1974; 18():51-129. PubMed ID: 4141523
    [No Abstract]   [Full Text] [Related]  

  • 37. A monoclonal antibody to a formaldehyde-resistant epitope on the nonpolymorphic constant part of the HLA-DR antigens.
    Sorg C; Bröcker EB; Zwadlo G; Redmann K; Feige U; Ax W; Feller AC
    Transplantation; 1985 Jan; 39(1):90-3. PubMed ID: 2578237
    [No Abstract]   [Full Text] [Related]  

  • 38. B cell positive cross-match not due to anti-HLA Class I antibodies and first kidney graft outcome.
    Praticò-Barbato L; Conca R; Magistroni P; Leonardi G; Oda A; Rosati F; Leone E; Tacconella M; Roggero S; Segoloni GP; Amoroso A
    Transpl Immunol; 2008 Jul; 19(3-4):238-43. PubMed ID: 18675725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possibility of a third sublocus.
    Kissmeyer-Nielsen F; Svejgaard A; Thorsby E
    Transplant Proc; 1971 Mar; 3(1):81-4. PubMed ID: 4106341
    [No Abstract]   [Full Text] [Related]  

  • 40. HL-A haplotypes and their inheritance.
    Svejgaard A; Hauge M; Kissmeyer-Nielsen F; Thorsby E
    Transplant Proc; 1971 Mar; 3(1):105-8. PubMed ID: 4106289
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.